-
EP3610022
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3610022
| EP3610022 - IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 11.09.2020 Database last updated on 22.08.2024 | |
| Former | Request for examination was made Status updated on 17.01.2020 | ||
| Former | The international publication has been made Status updated on 20.10.2018 | ||
| Former | unknown Status updated on 08.05.2018 | Most recent event Tooltip | 13.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Tallac Therapeutics, Inc. 866 Malcolm Road Suite 100 Burlingame, CA 94010 / US | [2022/28] |
| Former [2020/08] | For all designated states Tollnine, Inc. 1700 Owens Street San Francisco, CA 94158 / US | Inventor(s) | 01 /
SAKAMURI, Sukumar 11271 Laurelcrest Drive San Diego, California 92130 / US | 02 /
BRADSHAW, Curt W. 7980 Purple Sage San Diego, California 92127 / US | 03 /
LAM, Son 11334 Del Diablo Street San Diego, California 92129 / US | 04 /
STOCK, Joseph 4707 Otomi Avenue San Diego, California 92117 / US | 05 /
HA, Edward Hyungsuk 540 Via de la Valle Unit F Solana Beach, California 92075 / US | 06 /
ELTEPU, Laxman 10914 Ivy Hill Way, 5 San Diego, California 92131 / US | 07 /
LIU, Dingguo 11736 Miro Circle San Diego, California 92131 / US | 08 /
LIU, Bin 13571 Marguerite Creek Way San Diego, California 92130 / US | 09 /
DELLO IACONO, Giuseppe 435 Venetia Way Oceanside, California 92057 / US | 10 /
MEADE, Bryan R. 967 Beryl Street San Diego, California 92109 / US | 11 /
KABAKIBI, Ayman 5180 White Emerald Drive San Diego, California 92130 / US | [2020/08] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2020/08] | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | Application number, filing date | 18719793.4 | 13.04.2018 | [2020/08] | WO2018EP59554 | Priority number, date | US201762485748P | 14.04.2017 Original published format: US 201762485748 P | US201762537925P | 27.07.2017 Original published format: US 201762537925 P | [2020/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018189382 | Date: | 18.10.2018 | Language: | EN | [2018/42] | Type: | A1 Application with search report | No.: | EP3610022 | Date: | 19.02.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.10.2018 takes the place of the publication of the European patent application. | [2020/08] | Search report(s) | International search report - published on: | EP | 18.10.2018 | Classification | IPC: | C12N15/117 | [2020/08] | CPC: |
C07H21/04 (EP,IL,KR,US);
C12N15/117 (EP,IL,KR,US);
A61K2239/31 (EP,IL,KR,US);
A61K2239/38 (EP,IL,KR,US);
A61K2239/48 (EP,IL,KR,US);
A61K2239/50 (EP,IL,KR,US);
A61K2239/57 (EP,IL,KR,US);
A61K31/7125 (EP,IL,KR,US);
A61K39/0011 (EP,IL,KR,US);
A61K39/39 (EP,IL,KR,US);
A61K39/461 (EP,IL,KR,US);
A61K39/4615 (EP,IL,KR,US);
A61K39/4622 (EP,IL,KR,US);
A61K39/464411 (EP,IL,KR,US);
A61K39/464413 (EP,IL,KR,US);
A61K47/60 (IL,US);
A61K47/6807 (EP,IL,KR,US);
A61K47/6849 (EP,IL,KR,US);
A61K47/6883 (EP,IL,KR,US);
A61P35/00 (EP,IL,KR,US);
C07K16/2803 (EP,IL,KR,US);
C07K16/2812 (EP,IL,KR,US);
C07K16/2815 (EP,IL,KR,US);
C07K16/2818 (EP,IL,KR,US);
C07K16/2827 (EP,IL,KR,US);
C07K16/2833 (EP,IL,KR,US);
C07K16/2851 (EP,IL,KR,US);
C07K16/2863 (EP,IL,KR,US);
C07K16/2878 (EP,IL,KR,US);
C07K16/2887 (EP,IL,KR,US);
C07K16/2896 (EP,IL,KR,US);
C07K16/3084 (EP,IL,KR,US);
C07K7/06 (IL,US);
A61K2039/505 (EP,IL,KR,US);
A61K2039/507 (EP,IL,KR,US);
A61K2039/53 (IL,KR,US);
A61K2039/54 (EP,IL,KR,US);
A61K2039/55516 (EP,IL,KR,US);
A61K2039/55561 (EP,IL,KR,US);
A61K2039/572 (IL,KR,US);
C07K2319/40 (IL,KR,US);
C12N2310/17 (EP,IL,KR,US);
C12N2310/311 (EP,IL,KR,US);
C12N2310/315 (EP,IL,KR,US);
C12N2310/332 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/08] | Title | German: | IMMUNMODULIERENDE POLYNUKLEOTIDE, ANTIKÖRPERKONJUGATE DAVON UND VERFAHREN ZU DEREN VERWENDUNG | [2020/08] | English: | IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE | [2020/08] | French: | POLYNUCLÉOTIDES IMMUNOMODULATEURS, CONJUGUÉS D'ANTICORPS DE CEUX-CI, ET PROCÉDÉS D'UTILISATION ASSOCIÉS | [2020/08] | Entry into regional phase | 09.10.2019 | National basic fee paid | 09.10.2019 | Designation fee(s) paid | 09.10.2019 | Examination fee paid | Examination procedure | 09.10.2019 | Examination requested [2020/08] | 09.10.2019 | Date on which the examining division has become responsible | 29.05.2020 | Amendment by applicant (claims and/or description) | 10.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 18.01.2021 | Reply to a communication from the examining division | 31.03.2021 | Despatch of a communication from the examining division (Time limit: M04) | 14.07.2021 | Reply to a communication from the examining division | 08.04.2022 | Despatch of a communication from the examining division (Time limit: M04) | 12.07.2022 | Reply to a communication from the examining division | Fees paid | Renewal fee | 31.03.2020 | Renewal fee patent year 03 | 15.04.2021 | Renewal fee patent year 04 | 20.03.2022 | Renewal fee patent year 05 | 14.03.2023 | Renewal fee patent year 06 | 13.03.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2015069932 (SOLSTICE BIOLOG LTD [IE], et al); | [XYI]WO2015188197 (SOLSTICE BIOLOG LTD [IE], et al); | by applicant | US3687808 | US4845205 | US5130302 | US5134066 | US5175273 | US5367066 | US5432272 | US5457187 | US5459255 | US5484908 | US5502177 | US5525711 | US5552540 | US5587469 | US5594121 | US5596091 | US5614617 | US5681941 | WO9804727 | WO9837095 | US6054438 | US2006040887 | US2008286296 | US2010098704 | US2012041057 | WO2012092616 | WO2014011521 | US2014127197 | US2014205653 | WO2014179335 | WO2014179760 | US2015056224 | WO2015188197 | WO2016096174 | US9381208 | WO2017011444 | WO2017011622 | WO2017019846 | WO2017027645 | WO2017027646 | US2017057978 | WO2017049251 | US9650427 | US9663575 | US9738680 | US2017258897 | US2017267762 | US2017283498 | WO2017173427 | US2017298139 | US9803016 | US2017313776 | US2017313774 | US2017319680 | US9815898 | WO2017196867 | WO2017196793 | US9828434 | WO2017218435 | WO2017215590 | WO2017215585 | WO2017220990 | US2017369572 | US2018002423 | WO2018013017 | US2018022809 | US2018030137 | US2018028553 | WO2015US34749 |